Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Buy

A

Cerus Corp (CERS)

Surgical & Medical Instruments & Apparatus

http://www.cerus.com

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

1220 CONCORD AVENUE, SUITE 600
CONCORD, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/31/1997

Market Cap

412,285,825

Shares Outstanding

181,200,000

Weighted SO

181,197,000

Total Employees

N/A

Upcoming Earnings

08/07/2024

Similar Tickers

MXCT --.--%

SGHT --.--%

CVRX --.--%

NPCE --.--%

RPID --.--%

OFIX --.--%

NUVA --.--%

GKOS --.--%

HSKA --.--%

Beta

1.2010

Last Div

0.0000

Range

1.21-2.59

Chg

0.0350

Avg Vol

921624

Mkt Cap

412285825

Exch

NASDAQ

Country

US

Phone

925 288 6000

DCF Diff

1.0174

DCF

4.1374

Div Yield

0.0000

P/S

2.4254

EV Multiple

-17.2769

P/FV

8.3133

Div Yield %

0.0000

P/E

-17.1080

PEG

-0.7973

Payout

0.0000

Current Ratio

2.5059

Quick Ratio

1.8325

Cash Ratio

0.2302

DSO

50.9760

DIO

172.2074

Op Cycle

223.1834

DPO

79.4318

CCC

143.7516

Gross Margin

0.5475

Op Margin

-0.1949

Pretax Margin

-0.1410

Net Margin

-0.1415

Eff Tax Rate

-0.0070

ROA

-0.1297

ROE

-0.4819

ROCE

-0.2517

NI/EBT

1.0036

EBT/EBIT

0.7237

EBIT/Rev

-0.1949

Debt Ratio

0.4628

D/E

1.7338

LT Debt/Cap

0.5670

Total Debt/Cap

0.6342

Int Coverage

-7.3662

CF/Debt

-0.2696

Equity Multi

3.7467

Rec Turnover

7.1602

Pay Turnover

4.5951

Inv Turnover

2.1195

FA Turnover

9.7906

Asset Turnover

0.9164

OCF/Share

-0.1251

FCF/Share

-0.1455

Cash/Share

0.3849

OCF/Sales

-0.1362

FCF/OCF

1.1628

CF Coverage

-0.2696

ST Coverage

-1.1020

CapEx Coverage

-6.1406

Div&CapEx Cov

-6.1406

P/BV

8.3133

P/B

8.3133

P/S

2.4254

P/E

-17.1080

P/FCF

-15.3192

P/OCF

-17.7837

P/CF

-17.7837

PEG

-0.7973

P/S

2.4254

EV Multiple

-17.2769

P/FV

8.3133

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Jan 15, 09:30 3 Growth Stocks That Could Go Parabolic in 2024 Zacks Investment Research Nov 02, 17:25 Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates

Revenue Product Segmentation